The okadaic acid induced ACAT activation is prevented by a specific inhibitor of the Ca2+/calmodulin protein kinase II.
Hernández
M L
ML
Department of Physiology, University of the Basque Country Medical School, Bilbao, Spain.
Martínez
M J
MJ
Ochoa
B
B
D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / Q000031:analogs & derivatives / Q000494:pharmacology; D000818:Animals; D017871:Calcium-Calmodulin-Dependent Protein Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D002478:Cells, Cultured; D004789:Enzyme Activation; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D005260:Female; D007211:Indoles / Q000494:pharmacology; D007700:Kinetics; D008099:Liver / Q000201:enzymology*; D008301:Maleimides / Q000494:pharmacology; D009281:Naphthalenes / Q000494:pharmacology; D019319:Okadaic Acid / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D002785:Sterol O-Acyltransferase / Q000378:metabolism*
D004791:Enzyme Inhibitors; D007211:Indoles; D008301:Maleimides; D009281:Naphthalenes; D019319:Okadaic Acid; C063302:KN 62; D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; D002785:Sterol O-Acyltransferase; D017871:Calcium-Calmodulin-Dependent Protein Kinases; C058819:calphostin C; C088060:bisindolylmaleimide